Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Clinical trial NCT05529355 · UNKNOWN
Trial details
- NCT number
- NCT05529355
- Sponsor
- Anhui Chest Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-18
- Primary completion
- 2023-09-18
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.